Ticker League

Cash on Hand for Quest Diagnostics (DGX)

As of · Reported

Metric

Latest period

$393.00M

YoY change

-23.5%

5Y CAGR

-18.4%

Peak year (2019)

$1.19B

Cash on Hand history chart for Quest Diagnostics (DGX) from 1996 to 2025

Latest: $420.00M

Cash on Hand growth chart for Quest Diagnostics (DGX) from 1996 to 2025

Latest: -23.5%

Cash on Hand history table for Quest Diagnostics (DGX) from 1996 to 2025

  • 2025$420.00M-23.5%
  • 2024$549.00M-20.0%
  • 2023$686.00M+117.8%
  • 2022$315.00M-63.9%
  • 2021$872.00M-24.7%
  • 2020$1.16B-2.9%
  • 2019$1.19B+783.0%
  • 2018$135.00M-1.5%
  • 2017$137.00M-61.8%
  • 2016$359.00M+169.9%
  • 2015$133.00M-30.7%
  • 2014$192.00M+2.7%
  • 2013$187.00M-36.7%
  • 2012$295.60M+79.3%
  • 2011$164.90M-63.3%
  • 2010$449.30M-15.9%
  • 2009$534.30M+110.4%
  • 2008$253.90M+51.5%
  • 2007$167.59M+12.0%
  • 2006$149.64M+62.4%
  • 2005$92.13M+25.7%
  • 2004$73.30M-52.7%
  • 2003$154.96M+60.1%
  • 2002$96.78M-20.9%
  • 2001$122.33M-28.7%
  • 2000$171.48M+528.1%
  • 1999$27.30M-86.5%
  • 1998$202.90M+25.5%
  • 1997$161.70M+285.4%
  • 1996$41.96M—

Cash on Hand values are taken from Quest Diagnostics's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Cash on Hand at Quest Diagnostics (DGX)

According to Quest Diagnostics's latest reported financial statements, the company's latest reported cash and short-term investments is $393.00M. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Quest Diagnostics (DGX) most recent annual cash and short-term investments stands at $420.00M (2025) – declined 23.5% year-over-year.

Looking at the 2020–2025 (5 years) stretch, Quest Diagnostics cash and short-term investments compounded at -18.4% per year, with a net decline across the window.

Quest Diagnostics cash and short-term investments peaked at $1.19B in 2019; the latest annual figure is $420.00M in 2025 (64.8% below peak).

$1.19B stands as the all-time-high annual cash and short-term investments, posted in 2019, against a low of $27.30M during 1999.

Quest Diagnostics Cash on Hand by Year

Quest Diagnostics Cash on Hand 2025: $420.00M

Quest Diagnostics posted cash and short-term investments of $420.00M in 2025, declined 23.5% below 2024.

Quest Diagnostics Cash on Hand 2024: $549.00M

In 2024, Quest Diagnostics reported cash and short-term investments of $549.00M, declined 20.0% below 2023.

Quest Diagnostics Cash on Hand 2023: $686.00M

Quest Diagnostics cash and short-term investments in 2023 was $686.00M, surged 117.8% from 2022.

Quest Diagnostics Cash on Hand 2022: $315.00M

2022's cash and short-term investments for Quest Diagnostics came in at $315.00M, plunged 63.9% below 2021.

Quest Diagnostics Cash on Hand 2021: $872.00M

Quest Diagnostics cash and short-term investments in 2021 was $872.00M.

See more financial history for Quest Diagnostics (DGX).

Sector peers by Cash on Hand

Healthcare peers of Quest Diagnostics (DGX), ranked by their latest cash and short-term investments

Frequently asked questions

Quest Diagnostics (DGX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview